1.05 SEK
(3.38%)
Add to watchlist
Create an alert
Stocks and Shares ISABioInvent International AB is a Sweden-based biopharmaceutical company, that develops antibody-based drugs for cancer therapies, with two ongoing programs in Phase l/ll clinical trials for the treatment of haematological cancer and solid tumors. The Company’s operational activities are focused on expanding the clinical development of human antibodies, such as BI-1206, BI-1808, BI-1607 and BT-001. The Company has one wholly-owned subsidiary BioInvent Finans AB, which engaged in the administration of warrants issued by the Company.
Company Information
About this company
Key people
Martin Welschof
Chief Executive Officer
Stefan Ericsson
Chief Financial Officer
Marie Moores
Chief Operating Officer
Ashley Robinson
Senior Vice President - Strategy & Finance
Kristoffer Rudenholm Hansson
Senior Vice President - Technical Operations
Ingunn Munch Lindvig
Senior Vice President - Regulatory Affairs
Bjoern Frendeus
Chief Scientific Officer
Andres McAllister
Chief Medical Officer
Sylvie Ryckebusch
Chief Business Officer
Leonard Kruimer
Independent Chairman of the Board
Natalie Berner
Director
Elin Birgersson
Director, Employee Representative
Tomas Wall
Director, Employee Representative
Kristoffer Bissessar
Independent Director
Click to see more
Key facts
- Shares in issue65.80m
- EPICBINV
- ISINSE0015244520
- LocationSweden
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market capSEK 2.05bn
- Employees124
- ExchangeStockholm Stock Exchange
- IndexSX All Share PI Market Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.